Phenmetrazine
| Phenmetrazine | |
|---|---|
 | |
| Molecular structure via molpic based on CDK |
| Physical properties [] | |
|---|---|
| Molecular mass | 177.24 g/mol [1] |
| Appearance | Liquid [1] |
| Melting point | 139 °C [1] |
| Boiling point | 138-140 °C @ 12 mm Hg [1] |
| Decomposition | When heated to decomposition it emits toxic fumes of nitroxides. [1] |
| Solubility | >5 mg/L [1] |
| Predicted LogP | 1.4 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C11H15NO [1] |
| IUPAC name | 3-methyl-2-phenylmorpholine [1] |
| SMILES | CC1C(OCCN1)C2=CC=CC=C2 [1] |
| InChI | InChI=1S/C11H15NO/c1-9-11(13-8-7-12-9)10-5-3-2-4-6-10/h2-6,9,11-12H,7-8H2,1H3 [1] |
| InChIKey | OOBHFESNSZDWIU-UHFFFAOYSA-N [1] |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 16 – 31 hours |
Phenmetrazine (also known as 3-Methyl-2-phenylmorpholine, Oxazimedrine, Phenmetrazin, 2-Phenyl-3-methylmorpholine, Psychamine A 66, Probese-P, Fenmetrazin, Fenmetrazina, Defenmetrazin or Phenmetrazinum) is a
Chemistry
Stereochemistry []
Phenmetrazine is a racemic mixture of the diastereomers.
| Stereoisomerism |
|---|
| Stereoisomer enumberation with rdkit |
Legal status []
- Australia: Phenmetrazine is a S8 substance.
- Brazil: Phenmetrazine is a A3 substance.[2]
- Canada: Phenmetrazine is a Schedule IV substance.
- Germany: Phenmetrazine is a Anlage II substance.
- United Kingdom: Phenmetrazine is a Class B substance.
- United States: Phenmetrazine is a Schedule I under the "Controlled Substances Act (CSA)".
- United Nations: Phenmetrazine is a Schedule II drug under the "Convention on Psychotropic Substances 1971".
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 4762, phenmetrazine. Accessed May 11, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/4762
Anvisa. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. March 31, 2023. Accessed May 11, 2026. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992